Skye Bioscience, Inc. Annual Income Tax Expense (Benefit) in USD from 2012 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Skye Bioscience, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2012 to 2024.
  • Skye Bioscience, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $0.000.
  • Skye Bioscience, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $10.1K, a 180% increase year-over-year.
  • Skye Bioscience, Inc. annual Income Tax Expense (Benefit) for 2024 was $10.1K, a 180% increase from 2023.
  • Skye Bioscience, Inc. annual Income Tax Expense (Benefit) for 2023 was $3.6K, a 46.6% decline from 2022.
  • Skye Bioscience, Inc. annual Income Tax Expense (Benefit) for 2022 was $6.74K, a 221% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $10.1K +$6.47K +180% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 $3.6K -$3.14K -46.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 $6.74K +$4.64K +221% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $2.1K +$500 +31.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $1.6K $0 0% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $1.6K -$42 -2.56% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $1.64K +$42.00 +2.63% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-23
2017 $1.6K $0 0% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $1.6K -$116 -6.76% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-19
2015 $1.72K -$789 -31.5% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-10
2014 $2.51K Jan 1, 2014 Dec 31, 2014 10-K 2016-03-21
2012 $246 Nov 1, 2011 Oct 31, 2012 10-K 2014-01-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.